Literature DB >> 8160049

The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: clinical aspects.

B Currie1, D Howard, V T Nguyen, K Withnall, A Merianos.   

Abstract

From November 1990 to June 1991, 33 cases of acute melioidosis were diagnosed in tropical Northern Territory, Australia during an exceptionally wet monsoon. Eighteen (55%) were alcoholic, 16 (48%) diabetic and only 4 (12%, all survivors) had no risk factors. Twenty-seven (82%) were considered recent infection, with an incubation period of 3-21 days (mean 14) documented in eight cases with presumed cutaneous inoculation. Fourteen patients presented with pneumonia (4 septicemic) and of 11 others with septicemia 4 had genitourinary foci. Three of 4 with splenic abscesses required splenectomy. Three had only skin/soft tissue infection. One patient with brainstem encephalitis needed prolonged ventilation. Overall mortality was 36% (12 cases, including three relapses), despite therapy with ceftazidime and intensive care facilities. Pseudomonas pseudomallei is the commonest diagnosed cause of fatal bacteremic pneumonia at Royal Darwin Hospital and emphasis is placed on early appropriate antibiotic therapy and compliance with maintenance therapy for at least three months.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8160049

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  11 in total

Review 1.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Community-acquired Acinetobacter pneumonia.

Authors:  B Currie; D Fisher; N Anstey; K Withnall
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

3.  Evaluation of PCR for diagnosis of melioidosis.

Authors:  A Haase; M Brennan; S Barrett; Y Wood; S Huffam; D O'Brien; B Currie
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

4.  Detection of Burkholderia pseudomallei in soil within the Lao People's Democratic Republic.

Authors:  Vanaporn Wuthiekanun; Mayfong Mayxay; Wirongrong Chierakul; Rattanaphone Phetsouvanh; Allen C Cheng; Nicholas J White; Nicholas P J Day; Sharon J Peacock
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

5.  RAPD analysis of isolates of Burkholderia pseudomallei from patients with recurrent melioidosis.

Authors:  A Haase; A Melder; H Smith-Vaughan; D Kemp; B Currie
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

6.  Subdivision of Burkholderia pseudomallei ribotypes into multiple types by random amplified polymorphic DNA analysis provides new insights into epidemiology.

Authors:  A Haase; H Smith-Vaughan; A Melder; Y Wood; A Janmaat; J Gilfedder; D Kemp; B Currie
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

7.  The NarX-NarL two-component system regulates biofilm formation, natural product biosynthesis, and host-associated survival in Burkholderia pseudomallei.

Authors:  Mihnea R Mangalea; Bradley R Borlee
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

8.  Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection.

Authors:  Siew Hoon Sim; Yichun Liu; Dongling Wang; Vidhya Novem; Suppiah Paramalingam Sivalingam; Tuck Weng Thong; Eng Eong Ooi; Gladys Tan
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

Review 9.  Community-Acquired Pneumonia in the Asia-Pacific Region.

Authors:  Jae-Hoon Song; Kyungmin Huh; Doo Ryeon Chung
Journal:  Semin Respir Crit Care Med       Date:  2016-12-13       Impact factor: 3.119

Review 10.  Infective myositis, an uncommon presentation of melioidosis: a case report and review of the literature.

Authors:  Nuwan Jayawardena; Udaya Ralapanawa; Prabhashini Kumarihamy; Thilak Jayalath; Shashi Prabhani Abeygunawardana; Nadisha Dissanayake; Priyantha Dissanayake; Jeevani Udupihille; Neelakanthi Ratnatunga; Chamara Dalugama
Journal:  J Med Case Rep       Date:  2019-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.